Transmission electron micrograph of SARS-CoV-2 binding to the surfaces of cells they are attacking. A recent study from Johns Hopkins Medicine and the National Institute of Allergy and Infectious Diseases suggests vaccine-derived antibodies that prevent binding by the original strain of the virus do not work as well with the omicron strain. This may leave even vaccinated and boosted people open to breakthrough COVID-19.